武汉大学中南医院心血管内科 湖北 武汉 430071
金梦莹,女,1999—,医学硕士生,主要从事动脉粥样硬化机制研究,E⁃mail:2017302180262@whu.edu.cn
万静,女,1972—,医学博士,主任医师,教授,博士生导师,主要从事动脉粥样硬化机制研究,E⁃mail: wanjing_zn@163.com
收稿:2024-11-10,
纸质出版:2025-12-25
移动端阅览
金梦莹,张冰,彭爱红等.泛免疫炎症值与冠心病严重程度的相关性[J].武汉大学学报(医学版),2025,46(12):1605-1609.
JIN Mengying,ZHANG Bing,PENG Aihong,et al.Association between pan‑immune‑inflammation value and severity of coronary artery disease[J].Medical Journal of Wuhan University,2025,46(12):1605-1609.
金梦莹,张冰,彭爱红等.泛免疫炎症值与冠心病严重程度的相关性[J].武汉大学学报(医学版),2025,46(12):1605-1609. DOI: 10.14188/j.1671-8852.2024.0866.
JIN Mengying,ZHANG Bing,PENG Aihong,et al.Association between pan‑immune‑inflammation value and severity of coronary artery disease[J].Medical Journal of Wuhan University,2025,46(12):1605-1609. DOI: 10.14188/j.1671-8852.2024.0866.
目的
2
探讨泛免疫炎症值(PIV)与冠状动脉粥样硬化性心脏病(CAD)严重程度之间的关系。
方法
2
本研究纳入了2018年1月至2023年12月于武汉大学中南医院行冠状动脉造影确诊为冠心病的1 093名患者。根据PIV的三分位数,将所有患者分为三组。根据Gensini评分的中位数将CAD患者分为轻度狭窄组和重度狭窄组。
结果
2
研究结果显示PIV与CAD患者冠状动脉病变严重程度存在显著相关性,是CAD患者冠状动脉狭窄程度的独立危险因素。ROC曲线分析示,PIV预测重度狭窄CAD的曲线下面积为0.641,高于其他炎症生物标志物。
结论
2
CAD患者PIV值与冠状动脉狭窄的严重程度密切相关,且优于其他基于全血细胞计数的炎症生物标志物,因此
PIV可以作为CAD患者冠状动脉病变严重程度的预测指标。
Objective
2
To reveal the association between pan‑immune‑inflammation value (PIV) and coronary artery disease (CAD) severity.
Methods
2
This study enrolled 1 093 Chinese
Han
patients who were diagnosed with CAD by coronary angiography from January 2018 to December 2023. All patients were classified into three groups according to the tertiles of the PIV. CAD patients were divided into the mild stenosis group and the severe stenosis group according to the median Gensini score.
Results
2
A significant relationship between the PIV and the severity of CAD was observed
and PIV was an independent risk factor for coronary stenosis degree in patients with CAD. In terms of predictive
accuracy
the area under the ROC curve (
AUC
) of PIV for predicting severe stenosis CAD was 0.641
which was significantly higher than that of other inflammatory biomarkers.
Conclusion
2
PIV was associated with the severity of CAD and outperformed other complete blood count‑based inflammatory biomarkers. Therefore
PIV can serve as a predictor of the severity of CAD.
VOS T , ABAJOBIR A A , ABATE K H , et al . Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016 [J ] . Lancet , 2017 , 390 ( 10100 ): 1211 ‑ 1259 .
LIBBY P . Inflammation during the life cycle of the atherosclerotic plaque [J ] . Cardiovasc Res , 2021 , 117 ( 13 ): 2525 ‑ 2536 .
LI X , JI Y , KANG J , et al . Association between blood neutrophil‑to‑lymphocyte ratio and severity of coronary artery disease: Evidence from 17 observational studies involving 7017 cases [J ] . Medicine (Baltimore) , 2018 , 97 ( 39 ): e12432 .
JI H , LI Y , FAN Z , et al . Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: A syntax score assessment [J ] . BMC Cardiovasc Disord , 2017 , 17 ( 1 ): 90 .
QIU Z , JIANG Y , JIANG X , et al . Relationship between platelet to lymphocyte ratio and stable coronary artery disease: Meta‑analysis of observational studies [J ] . Angiology , 2020 , 71 ( 10 ): 909 ‑ 915 .
FUCÀ G , GUARINI V , ANTONIOTTI C , et al . The Pan‑Immune‑Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: Results from a pooled‑analysis of the Valentino and TRIBE first‑line trials [J ] . Br J Cancer , 2020 , 123 : 403 ‑ 409 .
巨名飞 , 董文超 , 于健 , 等 . 血常规中炎症指数与老年ACS患者冠状动脉狭窄严重程度的相关性 [J ] . 中国老年学杂志 , 2023 , 43 ( 9 ): 2060 ‑ 2063 .
JU M F , DONG W C , YU J , et al . Correlation between inflammatory index in blood routine and severity of coronary artery stenosis in elderly ACS patients [J ] . Chin J Gerontol , 2023 , 43 ( 9 ): 2060 ‑ 2063 .
BJÖRKEGREN J L M , LUSIS A J . Atherosclerosis: Recent developments [J ] . Cell , 2022 , 185 ( 10 ): 1630 ‑ 1645 .
SINNING C , LILLPOPP L , APPELBAUM S , et al . Angiographic score assessment improves cardiovascular risk prediction: The clinical value of SYNTAX and Gensini application [J ] . Clin Res Cardiol , 2013 , 102 ( 7 ): 495 ‑ 503 .
HILGENDORF I , SWIRSKI F K , ROBBINS C S . Monocyte fate in atherosclerosis [J ] . Arterioscler Thromb Vasc Biol , 2015 , 35 ( 2 ): 272 ‑ 279 .
MOORE K J , SHEEDY F J , FISHER E A . Macrophages in atherosclerosis: A dynamic balance [J ] . Nat Rev Immunol , 2013 , 13 : 709 ‑ 721 .
ZHANG X , KANG Z , YIN D , et al . Role of neutrophils in different stages of atherosclerosis [J ] . Innate Immun , 2023 , 29 ( 6 ): 97 ‑ 109 .
NORDING H M , SEIZER P , LANGER H F . Platelets in inflammation and atherogenesis [J ] . Front Immunol , 2015 , 6 : 98 .
LIBBY P . Inflammation in atherosclerosis [J ] . Arterioscler Thromb Vasc Biol , 2012 , 32 ( 9 ): 2045 ‑ 2051 .
MURAT B , MURAT S , OZGEYIK M , et al . Comparison of pan‑immune‑inflammation value with other inflammation markers of long‑term survival after ST‑segment elevation myocardial infarction [J ] . Eur J Clin Invest , 2023 , 53 ( 1 ): e13872 .
WU B , ZHANG C , LIN S , et al . The relationship between the pan‑immune‑inflammation value and long‑term prognoses in patients with hypertension: National Health and Nutrition Examination Study, 1999‑2018 [J ] . Front Cardiovasc Med , 2023 , 10 : 1099427 .
CETINKAYA Z , KELESOGLU S , TUNCAY A , et al . The role of pan‑immune‑inflammation value in determining the severity of coronary artery disease in NSTEMI patients [J ] . J Clin Med , 2024 , 13 ( 5 ): 1295 .
0
浏览量
9
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621